Skip to main content
Fig. 3 | Malaria Journal

Fig. 3

From: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda

Fig. 3

Uncorrected and PCR-corrected Kaplan–Meier survival curves of time to treatment failure among participants enrolled in therapeutic efficacy monitoring, Uganda, 2018–2019. AL artemether-lumefantrine, DP dihydroartemisinin-piperaquin

Back to article page